Healthcare provider profile · identity verified

Martha Anthony, MD

Internal Medicine · BROOKLYN, NY · NPI 1326066606

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	252	82
Levothyroxine Sodium	Levothyroxine Sodium	146	49
Rosuvastatin Calcium	Rosuvastatin Calcium	117	44
Metformin Hcl	Metformin Hcl	111	32
Omeprazole	Omeprazole	95	35
Albuterol Sulfate Hfa	Albuterol Sulfate	90	24
Amlodipine Besylate	Amlodipine Besylate	87	34
Losartan Potassium	Losartan Potassium	84	31
Metoprolol Succinate	Metoprolol Succinate	73	21
Famotidine	Famotidine	62	20
Alendronate Sodium	Alendronate Sodium	58	18
Montelukast Sodium	Montelukast Sodium	57	21
Gabapentin	Gabapentin	55	25
Lisinopril	Lisinopril	54	17
Enalapril Maleate	Enalapril Maleate	52	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	51	19
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	49	15
Glipizide	Glipizide	46	13
Carvedilol	Carvedilol	44	17
Fluticasone Propionate	Fluticasone Propionate	44	23
Hydrochlorothiazide	Hydrochlorothiazide	40	15
Mirtazapine	Mirtazapine	39	16
Pravastatin Sodium	Pravastatin Sodium	39	11
Tamsulosin Hcl	Tamsulosin Hcl	35	11
Meloxicam	Meloxicam	32	11
Sertraline Hcl	Sertraline Hcl	30	suppressed
Fenofibrate	Fenofibrate	28	suppressed
Ibandronate Sodium	Ibandronate Sodium	28	suppressed
Furosemide	Furosemide	27	11
Donepezil Hcl	Donepezil Hcl	26	suppressed
Diclofenac Sodium	Diclofenac Sodium	25	suppressed
Januvia	Sitagliptin Phosphate	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	19
Atenolol	Atenolol	23	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Ramipril	Ramipril	23	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	22	suppressed
Ozempic	Semaglutide	22	suppressed
Eliquis	Apixaban	21	suppressed
Methylprednisolone	Methylprednisolone	21	21
Vitamin D2	Ergocalciferol (Vitamin D2)	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	20	suppressed
Finasteride	Finasteride	19	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	19	suppressed
Simvastatin	Simvastatin	18	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	18	suppressed
Trazodone Hcl	Trazodone Hcl	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Prednisone	Prednisone	17	13
Vascepa	Icosapent Ethyl	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Metformin Hcl Er	Metformin Hcl	16	suppressed
Naproxen	Naproxen	16	suppressed
Alprazolam	Alprazolam	15	suppressed
Azithromycin	Azithromycin	15	15
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	15	suppressed
Entresto	Sacubitril/Valsartan	15	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Celecoxib	Celecoxib	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Clopidogrel	Clopidogrel Bisulfate	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Linzess	Linaclotide	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Glipizide Er	Glipizide	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Potassium Chloride	Potassium Chloride	12	suppressed
Prolia	Denosumab	12	suppressed
Single Use Swab	Alcohol Antiseptic Pads	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Glimepiride	Glimepiride	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Phenobarbital	Phenobarbital	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Spironolactone	Spironolactone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error